
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats
Cajsa Aranäs, Christian E. Edvardsson, Olesya T. Shevchouk, et al.
EBioMedicine (2023) Vol. 93, pp. 104642-104642
Open Access | Times Cited: 58
Cajsa Aranäs, Christian E. Edvardsson, Olesya T. Shevchouk, et al.
EBioMedicine (2023) Vol. 93, pp. 104642-104642
Open Access | Times Cited: 58
Showing 26-50 of 58 citing articles:
Neurocircuitry underlying the actions of glucagon-like peptide 1 and peptide YY3–36 in the suppression of food, drug-seeking, and anxiogenesis
Yasmina Dumiaty, Brett M. Underwood, Jenny Phy-Lim, et al.
Neuropeptides (2024) Vol. 105, pp. 102427-102427
Open Access | Times Cited: 4
Yasmina Dumiaty, Brett M. Underwood, Jenny Phy-Lim, et al.
Neuropeptides (2024) Vol. 105, pp. 102427-102427
Open Access | Times Cited: 4
A Complex Interplay between Nutrition and Alcohol use Disorder: Implications for Breaking the Vicious Cycle
Brooke White, Sunil Sirohi
Current Pharmaceutical Design (2024) Vol. 30, Iss. 23, pp. 1822-1837
Closed Access | Times Cited: 4
Brooke White, Sunil Sirohi
Current Pharmaceutical Design (2024) Vol. 30, Iss. 23, pp. 1822-1837
Closed Access | Times Cited: 4
The glucagon‐like peptide‐1 and other endocrine responses to alcohol ingestion in women with versus without metabolic surgery
Mariel Molina‐Castro, Neda Seyedsadjadi, Danisa Nieto, et al.
Addiction Biology (2024) Vol. 29, Iss. 10
Open Access | Times Cited: 4
Mariel Molina‐Castro, Neda Seyedsadjadi, Danisa Nieto, et al.
Addiction Biology (2024) Vol. 29, Iss. 10
Open Access | Times Cited: 4
Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic review
Mohsan Subhani, Ashwin Dhanda, James A. King, et al.
EClinicalMedicine (2024), pp. 102920-102920
Open Access | Times Cited: 4
Mohsan Subhani, Ashwin Dhanda, James A. King, et al.
EClinicalMedicine (2024), pp. 102920-102920
Open Access | Times Cited: 4
GLP-1 and its analogues: Does sex matter?
Stina Börchers, Karolina P. Skibicka
Endocrinology (2024)
Open Access | Times Cited: 4
Stina Börchers, Karolina P. Skibicka
Endocrinology (2024)
Open Access | Times Cited: 4
Effects of GLP‐1 Receptor Agonists in Alcohol Use Disorder
Mette Kruse Klausen, Gitte M. Knudsen, Tina Vilsbøll, et al.
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 3
Open Access
Mette Kruse Klausen, Gitte M. Knudsen, Tina Vilsbøll, et al.
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 3
Open Access
GLP-1 Receptor Agonists: Promising Therapeutic Targets for Alcohol Use Disorder
Elisabet Jerlhag
Endocrinology (2025) Vol. 166, Iss. 4
Open Access
Elisabet Jerlhag
Endocrinology (2025) Vol. 166, Iss. 4
Open Access
Baicalin affects dopamine homeostasis in the ADHD model by regulating the balance between DAT and VMAT2 transport via the activation of Nrf2/Keap-1/HO-1 signaling pathway
Xiangping Ding, Ma Bingxiang, Rui Zhou, et al.
Free Radical Biology and Medicine (2025)
Closed Access
Xiangping Ding, Ma Bingxiang, Rui Zhou, et al.
Free Radical Biology and Medicine (2025)
Closed Access
Association of Glucagon-Like Peptide-1 Receptor Agonist with Progression to Liver Cirrhosis and Alcohol-Related Admissions in Patients with Alcohol Use Disorder and Diabetes: A Retrospective Cohort Study
Feras Al-Moussally, Saud Khan, Vinay Katukuri, et al.
Drugs (2025)
Closed Access
Feras Al-Moussally, Saud Khan, Vinay Katukuri, et al.
Drugs (2025)
Closed Access
Therapeutic Potential of the Novel GLP-1 Receptor Agonist Semaglutide in Alcohol Use Disorder
Tingting Liu, Fuqiang Shi, Zhihua Guo, et al.
Pharmacopsychiatry (2025)
Closed Access
Tingting Liu, Fuqiang Shi, Zhihua Guo, et al.
Pharmacopsychiatry (2025)
Closed Access
An inhibitory GLP-1 circuit in the lateral septum modulates reward processing and alcohol intake in rodents
Christian E. Edvardsson, Davide Cadeddu, Mia Ericson, et al.
EBioMedicine (2025) Vol. 115, pp. 105684-105684
Closed Access
Christian E. Edvardsson, Davide Cadeddu, Mia Ericson, et al.
EBioMedicine (2025) Vol. 115, pp. 105684-105684
Closed Access
Decoding the influence of central LEAP2 on food intake and its effect on accumbal dopamine release
Maximilian Tufvesson‐Alm, Qian Zhang, Cajsa Aranäs, et al.
Progress in Neurobiology (2024) Vol. 236, pp. 102615-102615
Open Access | Times Cited: 3
Maximilian Tufvesson‐Alm, Qian Zhang, Cajsa Aranäs, et al.
Progress in Neurobiology (2024) Vol. 236, pp. 102615-102615
Open Access | Times Cited: 3
Antismoking agents do not contribute synergistically to semaglutide’s ability to reduce alcohol intake in rats
Cajsa Aranäs, Sebastian Blid Sköldheden, Elisabet Jerlhag
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Cajsa Aranäs, Sebastian Blid Sköldheden, Elisabet Jerlhag
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
GLP-1 receptor agonist semaglutide reduces appetite while increasing dopamine reward signaling
Karlijn L. Kooij, Derek IJsbrand Koster, E. Eeltink, et al.
Neuroscience Applied (2023) Vol. 3, pp. 103925-103925
Open Access | Times Cited: 7
Karlijn L. Kooij, Derek IJsbrand Koster, E. Eeltink, et al.
Neuroscience Applied (2023) Vol. 3, pp. 103925-103925
Open Access | Times Cited: 7
Response to semaglutide of non-drinker subjects with type 2 diabetes
Giovanni Petralli, Francesco Raggi, Alice Del Zoppo, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Giovanni Petralli, Francesco Raggi, Alice Del Zoppo, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Des-acyl ghrelin reduces alcohol intake and alcohol-induced reward in rodents
Sarah Witley, Christian E. Edvardsson, Cajsa Aranäs, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Sarah Witley, Christian E. Edvardsson, Cajsa Aranäs, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
MetALD: clinical aspects, pathophysiology and treatment
Jordi Gratacós‐Ginès, Sílvia Ariño, Pau Sancho‐Bru, et al.
JHEP Reports (2024) Vol. 7, Iss. 2, pp. 101250-101250
Closed Access | Times Cited: 2
Jordi Gratacós‐Ginès, Sílvia Ariño, Pau Sancho‐Bru, et al.
JHEP Reports (2024) Vol. 7, Iss. 2, pp. 101250-101250
Closed Access | Times Cited: 2
The GLP-1 receptor agonist exendin-4 reduces taurine and glycine in nucleus accumbens of male rats, an effect tentatively involving the nucleus tractus solitarius
Christian E. Edvardsson, Jesper Vestlund, Mia Ericson, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Christian E. Edvardsson, Jesper Vestlund, Mia Ericson, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
LEAP2, a ghrelin receptor inverse agonist, and its effect on alcohol-related responses in rodents
Maximilian Tufvesson‐Alm, Cajsa Aranäs, Sebastian Blid Sköldheden, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Maximilian Tufvesson‐Alm, Cajsa Aranäs, Sebastian Blid Sköldheden, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Gut Hormones: Possible Mediators of Addictive Disorders?
Liam J. Nestor, Karen D. Ersche
European Addiction Research (2024), pp. 1-8
Open Access | Times Cited: 1
Liam J. Nestor, Karen D. Ersche
European Addiction Research (2024), pp. 1-8
Open Access | Times Cited: 1
Spotlight on the Mechanism of Action of Semaglutide
Ilias Papakonstantinou, Konstantinos Tsioufis, Vasiliki Katsi
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 14514-14541
Open Access | Times Cited: 1
Ilias Papakonstantinou, Konstantinos Tsioufis, Vasiliki Katsi
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 14514-14541
Open Access | Times Cited: 1
Decoding the Influence of Central LEAP2 on Hedonic Food Intake and its association with Dopaminergic Reward Pathways
Maximilian Tufvesson‐Alm, Qian Zhang, Cajsa Aranäs, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Maximilian Tufvesson‐Alm, Qian Zhang, Cajsa Aranäs, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Inhibition of the Sodium–Calcium Exchanger Reverse Mode Activity Reduces Alcohol Consumption in Rats
Gleice Kelli Silva-Cardoso, Prosper N’Gouemo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4132-4132
Open Access
Gleice Kelli Silva-Cardoso, Prosper N’Gouemo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4132-4132
Open Access
Semaglutide+Reduces+Overconsumption+of+HFD+in+a+Rodent+Model+of+Binge+Eating
Jamila Guard
(2024)
Open Access
Jamila Guard
(2024)
Open Access
LEAP2, a ghrelin receptor inverse agonist, and its effect on alcohol-related responses in rodents
Maximilian Tufvesson‐Alm, Cajsa Aranäs, Sebastian Blid Sköldheden, et al.
Research Square (Research Square) (2024)
Closed Access
Maximilian Tufvesson‐Alm, Cajsa Aranäs, Sebastian Blid Sköldheden, et al.
Research Square (Research Square) (2024)
Closed Access